Pasar al contenido principal

NANOMATERIALS FOR BIOMEDICINE (I)

PRE2022-105709

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Desarrollar, Atraer y Retener Talento
Subprograma Subprograma Estatal de Formación
Convocatoria Contratos Predoctorales
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Multifunctional 3D-printed wound dressings containing a combination of synergistic antimicrobials in the management of MRSA infected topical wounds

  • Mattar, Iman
  • Landa, Guillermo
  • Frutos-Lizano, Marina
  • Izquierdo, Natalia
  • Tapia, Elena
  • Perez, Marta
  • Luján, Lluís
  • Irusta, Silvia
  • Mendoza, Gracia
  • Arruebo, Manuel
Despite increased pre- and postoperative care and aseptic practices in surgical rooms, methicillin-resistant Staphylococcus aureus (MRSA) continues to colonize acute surgical wounds. MRSA is also present in chronic nonhealing wounds, such as diabetic foot and pressure ulcers. In this work, advanced antimicrobial-loaded wound dressings are 3D printed using fused deposition modeling. To achieve a high antimicrobial effect, the topical antiseptic octenidine (OCT) was incorporated into the pellets used in the feeder of the extruder prior to fused modeling. Lysostaphin (LYS), a lytic enzyme that cleaves MRSA peptidoglycan, was incorporated by supramolecular interactions on the surface of the OCT-loaded dressings to exploit the anti-MRSA synergy identified here between OCT and LYS showing a fractional inhibition concentration index (FICI) of 0.156. Minimum inhibitory concentration (MIC) and bactericidal concentration (MBC) values for the OCT were 1 and 25 μg/mL, respectively, whereas the MIC and MBC values for the LYS were 0.1 and 0.2 μg/mL, respectively. The resulting dressings completely eradicate MRSA USA 300 inocula (105 CFU/mL) in 96 h. The bactericidal mechanisms exerted by these dressings were identified through molecular techniques, showing lytic effects on the cell wall peptidoglycans of treated bacteria. Additionally, OCT at 1 μg/mL was able to reduce lipopolysaccharide (100 ng/mL)-induced NO production on murine J774A.1 macrophages by more than 90% demonstrating its simultaneous anti-inflammatory action. This effect was also corroborated by the qRT-PCR analysis of several pro-inflammatory genes including IL-1β, IL-6, TNF-α, and Nos2. The combination of OCT and LYS within the dressings reveals higher in vivo therapeutic effects compared to free compounds or individual antimicrobial-loaded dressings. In vitro and in preclinical models, the use of OCT-LYS dressings effectively reduces MRSA bioburden and inflammation, promoting fast wound healing., The authors acknowledge the Spanish Ministry of Science and Innovation (Grants PID2020-113987RB-I00 and PID2023-146091OB-I00) for funding, and the Severo Ochoa Programme for Centers of Excellence in R&D (Grant CEX2023-001286-S MICIU/AEI/10.13039/501100011033). We also thank the financial support from Instituto de Salud Carlos III (Spain; Fortalece Call, Grant FORT23/00028). G.M. gratefully acknowledges the support from the Miguel Servet Program (Grant MS19/00092; Instituto de Salud Carlos III). I.M. acknowledges the support from the FPI program (Grant PRE2022-105709) awarded by the Spanish Ministry of Science and Innovation. We also thank the LMA-ELECMI ICTS (University of Zaragoza, Spain) and the Cell Culture, Flow Cytometry, and Cell Separation Core Units from IACS/IIS Aragon for their experimental support. We also acknowledge the Animal Facility, a joint service of IACS and the University of Zaragoza, as well as the Research Support Service (SAI) of the University of Zaragoza., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2023-001286-S)., Peer reviewed